Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study. [PDF]
Kay J +17 more
europepmc +1 more source
The 100 most-cited articles in COVID-19: a bibliometric analysis. [PDF]
Liew YY, Dong Q, Lakshman N, Khajuria A.
europepmc +1 more source
May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland. [PDF]
Jankowski P +19 more
europepmc +1 more source
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis. [PDF]
Furst DE +18 more
europepmc +1 more source
Outcomes of Voice Therapy in Behavioral Voice Disorders: A Scoping Review-Part A. [PDF]
Ribeiro VV +10 more
europepmc +1 more source
The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation. [PDF]
Góralczyk A +4 more
europepmc +1 more source
Psychological Contract Breach and Outcomes: A Systematic Review of Reviews. [PDF]
Topa G, Aranda-Carmena M, De-Maria B.
europepmc +1 more source
Ludowa wiara w moc słowa, czyli co łączy białoruskie zamowy z dawną niemiecką medycyną
Jadwiga Kozłowska-Doda
semanticscholar +1 more source

